Table 4 Number of patients receiving P. aeruginosa relevant antibiotics (ITT population)
From: A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
IC43 100 µg with adj(N = 104) No. (%) | IC43 100 µg w/o adj(N = 98) No. (%) | IC43 200 µg with adj(N = 101) No. (%) | Placebo(N = 98) No. (%) | Total(N = 401) No. (%) | |
|---|---|---|---|---|---|
Subjects with at least one P. aeruginosa relevant antibiotics during the study | 84 (80.8) | 76 (77.6) | 84 (83.2) | 83 (84.7) | 327 (81.5) |